Market brief — June 26, 2026

Yesterday, global markets closed mixed as a technology rout intensified, with the S&P 500 essentially flat at 7,357.49 (-0.01%) and the Nasdaq slipping 0.46% to 25,358.60, while European indices rallied on a rotation away from crowded AI trades: the CAC 40 gained 0.55% to 8,431.61, the DAX surged 1.03% to 24,994.83, and the Euro Stoxx 50 rose 0.85% to 6,267.53^[1][2]. This divergence reflects a systematic unwind of mega-cap chip valuations ahead of Micron Technology’s earnings, which later delivered a blockbuster forecast with gross margins near 85%, triggering a 17.5% premarket surge that now threatens to snap the Nasdaq’s three-day losing streak^[3]. The macro driver remains the repricing of the Fed’s rate path, with PCE inflation hitting a three-year high prompting analysts to argue rates may need to rise rather than fall, pushing futures to price a 36% probability of a 25-basis-point hike in July^[4].

Flows indicate a shift from discretionary risk-taking to CTA-driven de-risking, as yields climbed and semiconductor valuations faced scrutiny, yet the Micron beat is now injecting fresh momentum into the broader tech sector^[2]. Cross-asset confirmation shows yields dropping slightly after PCE data while oil prices rose nearly 3%, with WTI crude climbing above $70 a barrel, suggesting inflation expectations remain sticky despite equity volatility^[1]. The market is currently caught between a crowded short-covering rally in semiconductors and a broader de-risking event anchored by fears over AI capital deployment returns, creating a volatile regime where idiosyncratic earnings can override macro headwinds.

The Cash Scanner TOP 10 highlights this idiosyncratic momentum, with Applied Materials (AMAT) surging 13.4% to $668.00 on a 20-day breakout and ADX strength of 31, signaling a potential sector-wide reversal in semiconductors[Scanner]. AbbVie (ABBV) jumped 3.5% to $243.14 with a KST bullish crossover, while Bio-Techne (TECH) exploded 20.1% to $70.70 on volume and vortex signals, confirming life sciences tools as an early regime shift[Scanner]. US Foods Holding (USFD) and American Airlines (AAL) also broke out on 20-day levels with rising volume, indicating a rotation into US cyclicals and retail rather than pure tech momentum[Scanner]. The sector mix is concentrated in US tech and biotechnology, diverging from yesterday’s broad de-risking by showing early signs of earnings-driven recovery.

Today’s agenda includes the release of the PCE inflation data, which is likely to drive volatility in rates expectations and equity indices, particularly the Nasdaq if yields spike again^[4]. The Fed’s stress test results for major banks, which saw billions in dividends approved, may support financials and reduce credit spread volatility^[3]. Additionally, Micron Technology’s earnings reaction will be the primary catalyst for semiconductor flows, potentially dragging or lifting the broader tech sector depending on follow-through volume.

Key risks include a surprise upside in PCE inflation that could force the Fed to pivot toward rate hikes, breaking the current short-covering rally in equities^[4]. A liquidity event in crypto, with Bitcoin slipping below $60,000 ahead of a $10 billion options explosion, could spill into broader risk assets if institutional demand weakens further^[2]. Geopolitical escalation or a sudden drop in oil prices could also disrupt the current inflation narrative, altering the Fed’s path and triggering a fresh de-risking event.

Actionable lines include a long position in Applied Materials (AMAT) above $660 if volume confirms the 20-day breakout, with a stop below $650 to protect against a reversal[Scanner]. For the Nasdaq, a buy trigger above 25,400 is warranted if Micron’s post-earnings momentum sustains, while a breakdown below 25,200 would signal a return to the broader de-risking trend. Investors should also monitor AbbVie (ABBV) for a continuation of the KST bullish signal above $245, offering a defensive biotech entry in this volatile regime[Scanner].

Bonne journée aux p&l makers.